To test the therapeutic potential of the Crotalus venom peptide-rich fraction to treat type-2 diabetes and obesity, we used in vitro models to test insulin resistance and adipocyte lipid accumulation. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.